Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aktis Oncology
(AKTS) Q2 2026
Earnings
AKTS
May 11
Confirmed
Q3 2024
Q1 2025
Q4 2025
Q2 2026
-60.17
-40.13
-20.1
-0.06
Details
Expected EPS
-0.36154
Actual EPS
-0.38
Surprise EPS
-0.02
Surprise Percent
-5.11%
Description
Aktis Oncology (AKTS) has reported earnings of -0.38 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login